top of page
GWAS reveals mechanisms underlying DCM and myocardial resilience
01:01:05
Heart Muscle Talks

GWAS reveals mechanisms underlying DCM and myocardial resilience

Research paper presentation by Sean Jurgens from Amsterdam UMC.
Risk modeling in cardiomyopathies
01:05:44
Heart Muscle Talks

Risk modeling in cardiomyopathies

Round table discussion between Dr Menelaos Pavlou (UCL Department of Statistical Science), Dr Massimiliano Lorenzini and Dr Alexandros Protonotarios (UCL Institute of Cardiovascular Science).
The complex spectrum of Mendelian genetics in cardiomyopathies
59:05
Heart Muscle Talks

The complex spectrum of Mendelian genetics in cardiomyopathies

Lecture by Dr Roddy Walsh from Amsterdam UMC in February 2024 Visit https://www.heartmuscletalks.com or follow us at @heartmuscletalk for more!
Emerging Therapies for TransthyretinCardiac Amyloidosis
56:34
Heart Muscle Talks

Emerging Therapies for TransthyretinCardiac Amyloidosis

Lecture by Professor Mathew Maurer from Columbia University in January 2024 Visit https://www.heartmuscletalks.com or follow us at @heartmuscletalk for more!
Functional studies on Z-disc proteins and their role in cardiomyopathies
58:22
Heart Muscle Talks

Functional studies on Z-disc proteins and their role in cardiomyopathies

Lecture by Dr Katia Gehmlich from the University of Birmingham in September 2023. Visit https://www.heartmuscletalks.com or follow us at @heartmuscletalk for more!
Exercise recommendations in cardiomyopathies
56:28
Heart Muscle Talks

Exercise recommendations in cardiomyopathies

Lecture by Professor Sanjay Sharma from St George's, University of London in May 2023. Visit https://www.heartmuscletalks.com or follow as at @heartmuscletalk for more!
Cardiac outcomes in mitochondrial disease
56:12
Heart Muscle Talks

Cardiac outcomes in mitochondrial disease

Presentation by Dr Konstantinos Savvatis for the February 2023 session of the Heart Muscle Talks. Check our website at https://www.heartmuscletalks.com for future presentations.
The importance of the genotype on top of phenotype in managing dilated cardiomyopathies.
56:26
Heart Muscle Talks

The importance of the genotype on top of phenotype in managing dilated cardiomyopathies.

Abstract presentation by Dr Alessia Paladin and Dr Matteo Dal Ferro from Cardio-thoraco-vascular Department, University of Trieste, Italy at the October 2022, Heart Muscle Talks session. Visit https://www.heartmuscletalks.com or follow as at @heartmuscletalk for more!
Tracking and treating heart muscle inflammation.
01:02:23
Heart Muscle Talks

Tracking and treating heart muscle inflammation.

Lecture by Professor Federica Marelli-Berg from the William Harvey Research Institute, Queen Mary University of London at the July 2022, Heart Muscle Talks session. Visit https://www.heartmuscletalks.com or follow as at @heartmuscletalk for more!
Association between prophylactic ACEinhibitors and overall survival in Duchennemuscular dystrophy
58:43
Heart Muscle Talks

Association between prophylactic ACEinhibitors and overall survival in Duchennemuscular dystrophy

Abstract presentation by Dr Leslie Motté from Cochin Hospital, Paris, France at the June 2022, Heart Muscle Talks session. Visit https://www.heartmuscletalks.com or follow as at @heartmuscletalk for more!
Population prevalence of premature truncating variants in PKP2 and association with ARVC.
58:57
Heart Muscle Talks

Population prevalence of premature truncating variants in PKP2 and association with ARVC.

Abstract presentation by Robyn Hylind from Boston Children's Hospital, Boston, USA at the April 2022, Heart Muscle Talks session. Visit https://www.heartmuscletalks.com or follow as at @heartmuscletalk for more!
We see, but do not observe. Arrhythmogenic Cardiomyopathy revisited.
59:16
Heart Muscle Talks

We see, but do not observe. Arrhythmogenic Cardiomyopathy revisited.

Lecture by Professor Perry Elliott from the UCL Institute of Cardiovascular Science at the May 2022, Heart Muscle Talks session. Visit https://www.heartmuscletalks.com or follow as at @heartmuscletalk for more!
State-of-the-art human models to test effectiveness of old and new drugs for cardiomyopathies
01:03:41
Heart Muscle Talks

State-of-the-art human models to test effectiveness of old and new drugs for cardiomyopathies

Lecture by Professor Jolanda van der Velden from the University Medical Centre, Amsterdam, NL at the March 2022, Heart Muscle Talks session. Visit https://www.heartmuscletalks.com or follow as at @heartmuscletalk for more!
Natural History of HCM in NoonanSyndrome with MultipleLentigines (LEOPARD Syndrome)
09:52
Heart Muscle Talks

Natural History of HCM in NoonanSyndrome with MultipleLentigines (LEOPARD Syndrome)

presentation by Dr Emanuele Monda from the Department of Inherited and Rare Cardiovascular Diseases, University of Campania "Luigi Vanvitelli", Naples, Italy
Genetics in Arrhythmogenic Cardiomyopathy and implications for clinical practice
32:44
Heart Muscle Talks

Genetics in Arrhythmogenic Cardiomyopathy and implications for clinical practice

Presentation by Professor Petter Van Tintelen from UMC Utrecht, the Netherlands
Genetic Variants and outcomes in non-ischaemic dilated cardiomyopathy
16:11
Heart Muscle Talks

Genetic Variants and outcomes in non-ischaemic dilated cardiomyopathy

Presentation by Dr Luis Escobar-Lopez from the Heart Failure and Inherited Cardiac Diseases Unit, Hospital Universitario Puerta de Hierro, Madrid, Spain
bottom of page